981 results
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 6-9 November 2023 (new)
CHMP, Last updated: 10/11/2023 -
List item
Methodology Working Party stakeholder interaction meeting (updated)
Online, 07/12/2023, Last updated: 31/10/2023 -
List item
News: EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5 (new)
CHMP, Last updated: 31/10/2023 -
List item
Product Lifecycle Management (PLM) Value Stream Deep-Dive Webinar (updated)
Online 14:00 - 16:00 Amsterdam time (CEST), 30/11/2023, Last updated: 27/11/2023 -
List item
News: New treatment option for heavily pre-treated multiple myeloma patients
CHMP, Last updated: 13/10/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 October 2023
CHMP, Last updated: 13/10/2023 -
List item
News: EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep
CHMP, Last updated: 28/09/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023
CHMP, Last updated: 15/09/2023 -
List item
News: EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna
CHMP, Last updated: 05/10/2023 -
List item
News: Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5
CHMP, Last updated: 14/09/2023 -
List item
News: Comirnaty: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5
CHMP, Last updated: 30/08/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 July 2023
CHMP, Last updated: 21/07/2023 -
List item
News: First RSV vaccine to protect infants up to 6 months of age and older adults
CHMP, Last updated: 21/07/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 June 2023
CHMP, Last updated: 23/06/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 May 2023
CHMP, Last updated: 26/05/2023 -
List item
News: Revocation of authorisation for sickle cell disease medicine Adakveo
CHMP, Last updated: 26/05/2023 -
List item
News: First vaccine to protect older adults from respiratory syncytial virus (RSV) infection
CHMP, Last updated: 26/04/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24 - 26 April 2023
CHMP, Last updated: 26/05/2023 -
List item
News: EU recommendations for 2023-2024 seasonal flu vaccine composition
CHMP, Last updated: 04/04/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27 - 30 March 2023
CHMP, Last updated: 31/03/2023 -
List item
News: EMA recommends approval of Bimervax as a COVID-19 booster vaccine
CHMP, Last updated: 30/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 27-30 March 2023
European Medicines Agency, Amsterdam, the Netherlands, from 27/03/2023 to 30/03/2023, Last updated: 22/05/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 27-30 January 2025
European Medicines Agency, Amsterdam, the Netherlands, from 27/01/2025 to 30/01/2025, Last updated: 10/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-27 February 2025
European Medicines Agency, Amsterdam, the Netherlands, from 24/02/2025 to 27/02/2025, Last updated: 10/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-27 March 2025
European Medicines Agency, Amsterdam, the Netherlands, from 24/03/2025 to 27/03/2025, Last updated: 10/03/2023